Zai Lab Announces Participation in Investor Conference in January 2025
December 12 2024 - 7:30AM
Business Wire
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conference in January 2025:
43rd Annual J.P. Morgan Healthcare
Conference Presentation: Tuesday, January 14, 2025, 1:30 p.m.
PST Location: San Francisco
A live webcast of the presentation will be available on the
Investor Relations page of Zai Lab’s website at
ir.zailaboratory.com/webcasts-presentations and archived replay
will be available for up to 30 days following the completion of the
event.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, immunology, neuroscience, and infectious disease. Our
goal is to leverage our competencies and resources to positively
impact human health in China and worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241212395139/en/
Investor Relations: Christine Chiou / Lina Zhang +1 (917)
886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen +1 (857) 270-8854 /
+86 185 0015 5011 shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Dec 2023 to Dec 2024